Global Anthelmintics Market Size By Type (Triclabendazole, Thiabendazole), By Application (Hospitals, Homecare), By Region, And Segment Forecasts, 2023 to 2032

The Global Anthelmintics Market was valued at USD 4.2 billion in 2023 and is projected to surpass USD 6.8 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023-2031. The market growth is primarily driven by the increasing prevalence of parasitic infections in both humans and animals, rising demand for livestock healthcare, and advancements in drug formulations.

Anthelmintics, which include broad-spectrum and narrow-spectrum drugs, play a critical role in controlling helminthic infections, particularly in agriculture, veterinary medicine, and human healthcare. The growing emphasis on preventive healthcare and the increasing awareness of parasitic diseases are expected to further fuel market expansion.

Market Drivers

Increasing Incidence of Parasitic Infections

The rising burden of helminthic infections among humans and animals is one of the major driving forces behind the anthelmintics market. Poor sanitation, climate change, and increased human-animal interactions contribute to the spread of parasitic infections globally.

Rising Demand for Livestock Health Management

The expanding livestock industry, particularly in emerging economies, is fueling the demand for anthelmintic drugs. Proper parasite management in livestock improves productivity, enhances meat and dairy quality, and reduces economic losses.

Advancements in Drug Formulations

The development of novel anthelmintic formulations, including combination therapies and long-acting drugs, is boosting market growth. Innovations in drug delivery mechanisms, such as oral suspensions and injectables, enhance drug efficacy and ease of administration.

Market Restraints

Increasing Drug Resistance

The emergence of anthelmintic resistance in parasites poses a significant challenge to market growth. Repeated exposure to the same class of drugs has led to reduced efficacy, necessitating ongoing research and development for alternative treatments.

Regulatory and Approval Challenges

Strict regulatory frameworks for veterinary and human anthelmintic drugs can delay product approvals, thereby slowing market growth. Stringent quality control standards require extensive clinical testing, which increases the cost of drug development.

Market Opportunities

Growing Adoption of Combination Therapies

Pharmaceutical companies are focusing on developing combination anthelmintics to combat drug resistance and enhance treatment effectiveness. The growing trend toward multi-drug formulations is expected to provide new market opportunities.

Expansion in Emerging Markets

Developing regions such as Asia-Pacific, Latin America, and Africa are experiencing rising demand for anthelmintics due to growing livestock production and increasing awareness of parasitic infections. Government-led initiatives to improve animal health further support market expansion.

Market by Drug Type Insights

Broad-Spectrum Anthelmintics Dominate the Market

Broad-spectrum anthelmintics, such as albendazole, ivermectin, and fenbendazole, accounted for the largest market share in 2023. These drugs are widely used in both veterinary and human medicine due to their effectiveness against multiple parasitic species.

Narrow-Spectrum Anthelmintics Witness Moderate Growth

While broad-spectrum drugs dominate the market, narrow-spectrum anthelmintics targeting specific parasites, such as praziquantel (for schistosomiasis and tapeworm infections), continue to hold significant importance in targeted therapy.

Market by End-Use Insights

Veterinary Segment Leads the Market

The veterinary segment held the largest revenue share in 2023, driven by increasing livestock populations and the economic importance of parasite control in animal husbandry. Anthelmintics are widely used in cattle, poultry, swine, and companion animals.

Human Healthcare Segment Shows Steady Growth

The human healthcare segment is growing steadily due to the rising incidence of helminthic infections, particularly in tropical and subtropical regions. Increased government initiatives for deworming programs further contribute to market growth.

Market by Regional Insights

Asia-Pacific Leads the Market

Asia-Pacific dominated the global anthelmintics market in 2023, accounting for the largest share. The region's strong livestock industry, large human population, and high prevalence of parasitic infections drive market demand.

North America and Europe Show Strong Growth

North America and Europe are experiencing steady market growth, driven by robust research and development activities, advanced veterinary healthcare, and high awareness of anthelmintic treatments.

Competitive Scenario

Key players in the global anthelmintics market include:

Zoetis Inc.

Boehringer Ingelheim International GmbH

Elanco Animal Health Incorporated

Merck & Co., Inc.

Bayer AG

Virbac

Vetoquinol SA

Novartis AG

Johnson & Johnson

Sanofi S.A.

These companies focus on product innovation, strategic partnerships, and mergers & acquisitions to strengthen their market position.

Scope of Work – Global Anthelmintics Market

Key Market Developments

2023: Zoetis launched a novel long-acting anthelmintic formulation targeting multi-drug resistant parasites in livestock.

2024: Boehringer Ingelheim partnered with leading veterinary institutions to develop new combination anthelmintics for large-scale livestock management.

2025: Elanco introduced an innovative oral suspension anthelmintic for small companion animals, improving ease of administration and treatment compliance.

FAQs

1. What is the current market size of the Global Anthelmintics Market?

The Global Anthelmintics Market was valued at USD 4.2 billion in 2023.

2. What is the major growth driver of the Global Anthelmintics Market?

The market is primarily driven by the increasing prevalence of parasitic infections and the rising demand for livestock healthcare solutions.

3. Which region is expected to dominate the market during the forecast period?

Asia-Pacific is expected to lead the market due to its large livestock population and high incidence of parasitic infections.

4. Which segment accounted for the largest market share in the Global Anthelmintics Market?

The veterinary segment accounted for the largest market share in 2023, driven by the need for parasite control in livestock.

5. Who are the key market players in the Global Anthelmintics Market?

Major players include Zoetis Inc., Boehringer Ingelheim, Elanco, Merck, Bayer, Virbac, Vetoquinol, Novartis, Johnson & Johnson, and Sanofi.

This detailed market report provides an in-depth analysis of the Global Anthelmintics Market, ensuring comprehensive insights for stakeholders and industry players.